Alison
May 9th, 2025
3:09 am
Thank you for sharing. Up to date and intriguing.
#perfusionist #perfusion #healthcare
Our Webinar is reschedule for 4.20.2023 @ 9am due to emegency.
SARS-CoV-2 Versus Influenza - associated Acute Respiratory Distress Syndrome Requiring Veno-venous Extracorporeal Membrane Oxygenation Support.
The COVID pandemic resulted in a substantial increase of ECMO use. Many new programs and technology emerged out of need and growth of ECMO is projected to continue. What did we learn? The program will explore lessons learned.
Unraveling SARS-CoV-2 Versus Influenza: Lessons Learned from Acute Respiratory Distress Syndrome and the ECMO Surge
Welcome to our eye-opening YouTube video, where we embark on a compelling journey of discovery - the battle between SARS-CoV-2 and influenza, and their impact on Acute Respiratory Distress Syndrome (ARDS). The COVID-19 pandemic triggered a substantial surge in Extracorporeal Membrane Oxygenation (ECMO) utilization, giving rise to new programs and cutting-edge technology. In this program, we delve into the invaluable lessons learned during these unprecedented times.
Join us as we dissect the differences between SARS-CoV-2 and influenza, and how they manifest in ARDS. This insightful exploration will provide a deeper understanding of the pathophysiological intricacies of these viral infections and their implications for respiratory health.
The COVID-19 pandemic exerted immense pressure on healthcare systems, leading to an unparalleled increase in ECMO use. We'll explore the emergence of new ECMO programs and technology born out of necessity, aiming to save lives and meet the demands of the crisis. Understanding the challenges faced and innovations developed during this period will shed light on the resilience and adaptability of medical communities worldwide.
As we navigate through the wealth of data and experiences accumulated, we'll analyze the projected growth of ECMO use beyond the pandemic. What does the future hold for this life-saving technology? Our program will address this question, offering insights into how ECMO may continue to play a pivotal role in enhancing critical care across various medical scenarios.
The lessons learned during the pandemic are invaluable, and in this video, we strive to share those insights with you. Our objective is to facilitate meaningful discussions and promote continued learning among medical professionals, students, and viewers alike.
Be a part of this engaging and informative experience as we unravel the impact of SARS-CoV-2 and influenza on ARDS and the remarkable growth of ECMO technology. Like, subscribe, and hit the notification bell to stay updated with our latest content on vital medical topics. Let's explore the lessons we've gained from these unprecedented times and embrace the future of critical care together. See you in the video!
Register and watch for free @ Perfusion Library
Get our Perfusion App - Here
IV Dosage and Rate Calculator - Here
Subscribe to our podcast:
Apple Podcasts
Google Podcasts
Spotify
Visit our websites:
MediWeb
PerfWeb
Perfusion Education
See Our Schedule: - Here
Joseph has been a practicing clinical perfusionist for 40 years. Joseph is the CEO of Houston Extracorporeal Technologies and is the program director of The New Orleans Conference
